“President Donald Trump’s surgeon general nominee reported investments in the tobacco company Philip Morris International,” NewsNation reports.“Nicole Saphier disclosed these investments in an ethics agreement, where she pledged to completely or partially divest from those companies, as well as shed stock holdings with a host of pharmaceutical and biotechnology industry leaders — including Eli Lilly, Biogen, Johnson & Johnson, Pfizer, AstraZeneca, Merck, AbbVie and more.”